Loading clinical trials...
Loading clinical trials...
Reduction of Corticosteroid Use in Outpatient Treatment of Exacerbated COPD - a Randomized, Double-blind, Non-inferiority Study (The "RECUT"-Trial)
Conditions
Interventions
Placebo
Prednisone
Locations
1
Switzerland
Kantonsspital Baselland
Liestal, Basel-Landschaft, Switzerland
Start Date
March 1, 2015
Primary Completion Date
July 31, 2024
Completion Date
July 31, 2024
Last Updated
March 12, 2025
NCT06831994
NCT02755974
NCT05050591
NCT05913765
NCT05592847
NCT00683722
Lead Sponsor
Prof. Dr. Jörg Leuppi
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions